← back to search

Heiko‐Manuel Teltschik

University of Tübingen · DE
Area of research
Hematology · Immunology
Research interest
Research focused on Minimal residual disease and Blinatumomab, with related work in Current (fluid), Stem cell, Antibody-dependent cell-mediated cytotoxicity. Notable publications include 'Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab', 'CD34 + selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation', and 'Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody'.
h-index
—
citations
202
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland
Mycoses 2025cited by 1position: middledoi
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
British Journal of Haematology 2017cited by 47position: middledoi
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody
Molecular Therapy 2016cited by 20position: middledoi
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Haematologica 2014cited by 134position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin Ebinger · German Cancer Research Center3 papers (2014–2017)Tobias Feuchtinger · Centro de Investigación del Cáncer3 papers (2014–2017)Rupert Handgretinger · University College London3 papers (2014–2017)Peter Lang · Temple Street Children's University Hospital3 papers (2014–2017)Patrick Schlegel · University of Regensburg2 papers (2016–2017)Ludger Große‐Hovest · University of Tübingen1 papers (2016–2016)Chiara Mainardi · University of Padua1 papers (2017–2017)Judith Feucht · Kettering University1 papers (2014–2014)Hermann Kreyenberg · Goethe University Frankfurt1 papers (2014–2014)Christina Kyzirakos · University of Tübingen1 papers (2014–2014)Ingo Müller · Kinderkrebs-Zentrum Hamburg1 papers (2017–2017)Carl-Philipp Schwarze · University of Tübingen1 papers (2016–2016)P. Schlegel · University of Tübingen1 papers (2014–2014)Ursula Holzer · University of Tübingen1 papers (2017–2017)Gerhard Zugmaier · Amgen (Germany)1 papers (2014–2014)Matthias Eyrich · Max Delbrück Center1 papers (2017–2017)Michael Schumm · University of Tübingen1 papers (2017–2017)— · 1 papers (2016–2016)Michaela Döring · University of Tübingen1 papers (2017–2017)Kai Witte · University of Tübingen1 papers (2014–2014)